Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb–IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)
Titel:
Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb–IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)
Auteur:
Stadler, Rudolf Romero, Pablo Ortiz Bagot, Martine Quaglino, Pietro Guenova, Emmanuella Jonak, Constanze Papadavid, Evangelina Stranzenbach, René Sartori, Delphine Musoro, Jammbe Z. Falato, Claudette Marreaud, Sandrine Scarisbrick, Julia Jane Knobler, Robert